Defense innovation unit exhaled breath diagnostics prototype project
Ended Other Transaction Agreement Awarded Last action
- Contract number
- HQ00342390002
- Awardee
-
Owlstone Medical LIMITED UEI FDLYKL86LUN8
- Awarding agency
-
Washington Headquarters Service
Department of Defense
- Obligated
- $4,039,388
Award facts
- Contract value 75% obligated
-
- $4,039,388.00 Current, with exercised options
- $5,363,842.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Threat Reduction Agency Department of Defense
- NAICS code
- Not on record
- Set-aside
- No set-aside
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Great Britain, United Kingdom
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $946,919 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $114,220 | |
| Funding Only Action | $0 | |
| Supplemental Agreement for work within scope | $889,461 | |
| Supplemental Agreement for work within scope | $114,220 | |
| Supplemental Agreement for work within scope | -$114,220 | |
| Supplemental Agreement for work within scope | $0 | |
| Funding Only Action | $1,296,372 | |
| Original award | $792,416 |
About this award
The Defense Threat Reduction Agency (DTRA) awarded Owlstone Medical Limited, a UK-based breath analysis technology company, a $5.36 million Other Transaction Agreement on March 22, 2023, for the Defense Innovation Unit Exhaled Breath Diagnostics Prototype Project. The prototype development effort, which operates under an open competition framework with no set-asides, is scheduled for completion by March 31, 2026, and will be performed in Great Britain. This award reflects DTRA's interest in advancing innovative diagnostic capabilities with potential national security applications through the Defense Innovation Unit's prototyping initiatives.
Owlstone Medical specializes in manufacturing advanced breath sampling equipment and diagnostic technologies for medical and defense applications. The company has established itself as a key federal contractor, with prior awards including purchase orders from the U.S. Navy's Bureau of Medicine and Surgery for breath sampling equipment and a recent order from the Food and Drug Administration. This contract award demonstrates continued federal investment in Owlstone's breath-based diagnostic solutions and positions the company as a primary developer of exhaled breath analysis technology for DTRA's research objectives.
Quick answers
Who was awarded contract HQ00342390002?
HQ00342390002 was awarded to Owlstone Medical LIMITED by Washington Headquarters Service (Department of Defense) on March 22, 2023.
How much is contract HQ00342390002 worth?
The government has obligated $4,039,388 on HQ00342390002. Its potential value, with all options, is $5,363,842.
Which agency awarded contract HQ00342390002?
Washington Headquarters Service (Department of Defense) awarded HQ00342390002, with funding from Defense Threat Reduction Agency (Department of Defense).
Was contract HQ00342390002 competed?
The extent of competition for HQ00342390002 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award